{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:14:56Z","timestamp":1792682096137,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13054-016-1267-8","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T13:49:20Z","timestamp":1459432160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections"],"prefix":"10.1186","volume":"20","author":[{"given":"Philippe","family":"Montravers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Grall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Desmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Allou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Marmuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Guglielminotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,7]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"crossref","unstructured":"Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, et al. Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams. Clin Microbiol Infect. 2015;21:649.e1\u201310.","DOI":"10.1016\/j.cmi.2015.03.013"},{"key":"1267_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan Jr JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis"},{"key":"1267_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165\u2013228.","journal-title":"Intensive Care Med"},{"key":"1267_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Guti\u00e9rrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fern\u00e1ndez-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40:32\u201340.","journal-title":"Intensive Care Med"},{"key":"1267_CR5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00134-007-0619-x","volume":"33","author":"E Giantsou","year":"2007","unstructured":"Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med. 2007;33:1533\u201340.","journal-title":"Intensive Care Med"},{"key":"1267_CR6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00003246-200107000-00029","volume":"29","author":"MH Kollef","year":"2001","unstructured":"Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med. 2001;29:1473\u20135.","journal-title":"Crit Care Med"},{"key":"1267_CR7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.ccx.0000244126.84989.a2","volume":"12","author":"MS Niederman","year":"2006","unstructured":"Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care. 2006;12:452\u20137.","journal-title":"Curr Opin Crit Care"},{"key":"1267_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00134-013-3154-y","volume":"40","author":"MH Kollef","year":"2014","unstructured":"Kollef MH. What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med. 2014;40:92\u20135.","journal-title":"Intensive Care Med"},{"key":"1267_CR9","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/cc4919","volume":"10","author":"F Alvarez-Lerma","year":"2006","unstructured":"Alvarez-Lerma F, Alvarez B, Luque P, Ruiz F, Dominguez-Roldan JM, Quintana E, et al. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care. 2006;10:R78.","journal-title":"Crit Care"},{"key":"1267_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/TA.0b013e31819dca4e","volume":"66","author":"SR Eachempati","year":"2009","unstructured":"Eachempati SR, Hydo LJ, Shou J, Barie PS. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma. 2009;66:1343\u20138.","journal-title":"J Trauma"},{"key":"1267_CR11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMoa052904","volume":"355","author":"Canadian Critical Care Trials Group","year":"2006","unstructured":"Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619\u201330.","journal-title":"N Engl J Med"},{"key":"1267_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.CCM.0000253404.69418.AA","volume":"35","author":"M Leone","year":"2007","unstructured":"Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanese J, et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med. 2007;35:379\u201385.","journal-title":"Crit Care Med"},{"key":"1267_CR13","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.CCM.0000145997.10438.28","volume":"32","author":"J Rello","year":"2004","unstructured":"Rello J, Vidaur L, Sandiumenge A, Rodriguez A, Gualis B, Boque C, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004;32:2183\u201390.","journal-title":"Crit Care Med"},{"key":"1267_CR14","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e3182416ecf","volume":"40","author":"S Heenen","year":"2012","unstructured":"Heenen S, Jacobs F, Vincent JL. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often? Crit Care Med. 2012;40:1404\u20139.","journal-title":"Crit Care Med"},{"key":"1267_CR15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.CCM.0000050298.59549.4A","volume":"31","author":"M Leone","year":"2003","unstructured":"Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462\u20137.","journal-title":"Crit Care Med"},{"key":"1267_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00134-013-3148-9","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med. 2014;40:41\u20139.","journal-title":"Intensive Care Med"},{"key":"1267_CR17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1469-0691.2010.03360.x","volume":"17","author":"P Montravers","year":"2011","unstructured":"Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2011;17:1061\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"1267_CR18","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc9373","volume":"14","author":"J Morel","year":"2010","unstructured":"Morel J, Casoetto J, Jospe R, Aubert G, Terrana R, Dumont A, et al. De-escalation as part of a global strategy of empiric antibiotherapy management: a retrospective study in a medico-surgical intensive care unit. Crit Care. 2010;14:R225.","journal-title":"Crit Care"},{"key":"1267_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jhin.2004.09.014","volume":"59","author":"MM Warren","year":"2005","unstructured":"Warren MM, Gibb AP, Walsh TS. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital. J Hosp Infect. 2005;59:90\u20135.","journal-title":"J Hosp Infect"},{"key":"1267_CR20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cid\/civ1199","volume":"62","author":"A Tabah","year":"2016","unstructured":"Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis. 2016;62:1009\u201317.","journal-title":"Clin Infect Dis"},{"key":"1267_CR21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcrc.2009.11.007","volume":"25","author":"JJ Waele De","year":"2010","unstructured":"De Waele JJ, Ravyts M, Depuydt P, Blot SI, Decruyenaere J, Vogelaers D. De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care. 2010;25:641\u20136.","journal-title":"J Crit Care"},{"key":"1267_CR22","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/cc12819","volume":"17","author":"L Gonzalez","year":"2013","unstructured":"Gonzalez L, Cravoisy A, Barraud D, Conrad M, Nace L, Lemari\u00e9 J, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care. 2013;17:R140.","journal-title":"Crit Care"},{"key":"1267_CR23","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc8877","volume":"14","author":"P Augustin","year":"2010","unstructured":"Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care. 2010;14:R20.","journal-title":"Crit Care"},{"key":"1267_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13054-015-0789-9","volume":"19","author":"P Montravers","year":"2015","unstructured":"Montravers P, Dufour G, Guglieminotti J, Desmard M, Muller C, Houissa H, et al. Dynamic changes of microbial flora and therapeutic consequences in persistent intra-abdominal sepsis. Crit Care. 2015;19:70.","journal-title":"Crit Care"},{"key":"1267_CR25","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s11695-013-0955-6","volume":"23","author":"P Montravers","year":"2013","unstructured":"Montravers P, Guglielminotti J, Zappella N, Desmard M, Muller C, Fournier P, et al. Clinical features and outcome of postoperative peritonitis following bariatric surgery. Obes Surg. 2013;23:1536\u201344.","journal-title":"Obes Surg"},{"issue":"11 Suppl","key":"1267_CR26","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1097\/01.CCM.0000143119.41916.5D","volume":"32","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S513\u201326.","journal-title":"Crit Care Med"},{"key":"1267_CR27","unstructured":"Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CASFM) 2011. Recommandations 2011. Paris: Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie; 2011. http:\/\/www.sfm-microbiologie.org\/UserFiles\/files\/casfm\/casfm_2011.pdf . Accessed 4 December 2015."},{"key":"1267_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"1267_CR29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/01.CCM.0000053525.49267.77","volume":"31","author":"H Dupont","year":"2003","unstructured":"Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med. 2003;31:752\u20137.","journal-title":"Crit Care Med"},{"key":"1267_CR30","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Gall Le","year":"2003","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA. 2003;270:2957\u201363.","journal-title":"JAMA"},{"key":"1267_CR31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"1267_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","volume":"110","author":"WR McCabe","year":"1962","unstructured":"McCabe WR, Jackson GG. Gram-negative bacteremia. 1. Etiology and ecology. Arch Intern Med. 1962;110:847\u201355.","journal-title":"Arch Intern Med"},{"key":"1267_CR33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/23.3.486","volume":"23","author":"P Montravers","year":"1996","unstructured":"Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23:486\u201394.","journal-title":"Clin Infect Dis"},{"key":"1267_CR34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00134-002-1250-5","volume":"28","author":"C Paugam-Burtz","year":"2002","unstructured":"Paugam-Burtz C, Dupont H, Marmuse JP, Chosidow D, Malek L, Desmonts JM, et al. Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis. Intensive Care Med. 2002;28:594\u20138.","journal-title":"Intensive Care Med"},{"key":"1267_CR35","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/cc9961","volume":"15","author":"P Montravers","year":"2010","unstructured":"Montravers P, Dupont P, Gauzit R, Veber B, Bedos JP, Lepape A, et al. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care. 2010;15:R17.","journal-title":"Crit Care"},{"key":"1267_CR36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00003246-200106000-00003","volume":"29","author":"EH Ibrahim","year":"2001","unstructured":"Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001;29:1109\u201315.","journal-title":"Crit Care Med"},{"key":"1267_CR37","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","volume":"125","author":"ST Micek","year":"2004","unstructured":"Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125:1791\u20139.","journal-title":"Chest"},{"key":"1267_CR38","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1378\/chest.128.4.2778","volume":"128","author":"GW Soo Hoo","year":"2005","unstructured":"Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest. 2005;128:2778\u201387.","journal-title":"Chest"},{"key":"1267_CR39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.129.5.1210","volume":"129","author":"MH Kollef","year":"2006","unstructured":"Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006;129:1210\u20138.","journal-title":"Chest"},{"key":"1267_CR40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanese J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014;40:1399\u2013408.","journal-title":"Intensive Care Med"},{"key":"1267_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133\u201364.","journal-title":"Clin Infect Dis"},{"key":"1267_CR42","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s00134-015-4016-6","volume":"41","author":"A Paskovaty","year":"2015","unstructured":"Paskovaty A, Pastores SM, Gedrimaite Z, Kostelecky N, Riedel ER, Seo SK. Antimicrobial de-escalation in septic cancer patients: is it safe to back down? Intensive Care Med. 2015;41:2022\u20133.","journal-title":"Intensive Care Med"},{"key":"1267_CR43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IPC.0b013e318279ee87","volume":"21","author":"E Knaak","year":"2013","unstructured":"Knaak E, Cavalieri SJ, Elsasser GN, Preheim LC, Gonitzke A, Destache CJ. Does antibiotic de-escalation for nosocomial pneumonia impact intensive care unit length of stay? Infect Dis Clin Pract. 2013;21:172\u20136.","journal-title":"Infect Dis Clin Pract"},{"key":"1267_CR44","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/cc10072","volume":"15","author":"MK Joung","year":"2011","unstructured":"Joung MK, Lee JA, Moon SY, Cheong HS, Joo EJ, Ha YE, et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care. 2011;15:R79.","journal-title":"Crit Care"},{"key":"1267_CR45","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00134-014-3485-3","volume":"40","author":"JF Timsit","year":"2014","unstructured":"Timsit JF, Harbarth S, Carlet J. De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensive Care Med. 2014;40:1580\u20132.","journal-title":"Intensive Care Med"},{"issue":"Suppl 6","key":"1267_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1469-0691.12622","volume":"20","author":"M Ruhnke","year":"2014","unstructured":"Ruhnke M. Antifungal stewardship in invasive Candida infections. Clin Microbiol Infect. 2014;20 Suppl 6:11\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"1267_CR47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ijcp.12231","volume":"68","author":"AM Bal","year":"2014","unstructured":"Bal AM, Shankland GS, Scott G, Imtiaz T, Macaulay R, McGill M. Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience. Int J Clin Pract. 2014;68:20\u20137.","journal-title":"Int J Clin Pract"},{"key":"1267_CR48","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","volume":"41","author":"S Bailly","year":"2015","unstructured":"Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, et al. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Intensive Care Med. 2015;41:1931\u201340.","journal-title":"Intensive Care Med"},{"key":"1267_CR49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","volume":"40","author":"E Azoulay","year":"2012","unstructured":"Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, et al. Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med. 2012;40:813\u201322.","journal-title":"Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1267-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T05:44:56Z","timestamp":1498283096000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-016-1267-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s13054-016-1267-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,7]]},"article-number":"83"}}